ONCoV-Logo_WhiteFont.png

Ontario’s COVID-19 Genomics Rapid Response Coalition 

 

    About    

To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.

Genomics

Infrastructure

Standardized Sequencing Methodologies

Bioinformatics

Infrastructure

Data Management & Sharing

The ON-CoV Coalition is designed to provide for method standardization and coordination of:

1

Collecting Patient Samples and Metadata

2

Sequencing

3

Data Curation and Management

4

Epidemiological Studies 

This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.

Why Genomics?

Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19

pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19. 

The results reported by the Coalition will inform vaccine and therapeutic development.

Why Ontario Genomics?

Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms. 

Ontario Genomics is well-positioned to provide and promote:
W-Collaboration.png
COLLABORATION
W-Leadership.png
LEADERSHIP
W-Expertise.png
EXPERTISE
 

    Members    

ONCoV Genomics Coalition Members

Aaron Campigotto

University of Toronto

Bettina Hamelin

Ontario Genomics

Samira Mubareka

Sunnybrook Health Sciences / University of Toronto

Danielle Brabant-Kirwan

Health Sciences North

Robyn Lee

Dalla Lana School of Public Health, University of Toronto

Letitia Nadalin Penno

Canadore College

Nahuel Fittipaldi

Public Health Ontario

Andrew G. McArthur

McMaster University

Marc Fiume

DNAstack

Allison McGeer

Sinai Health Systems

Stephen Scherer

Hospital for Sick Children / University of Toronto

TCAG / CGEn

Prameet M. Sheth

Kingston Health Sciences Centre / Queen’s University

Jared Simpson

Ontario Institute for Cancer Research

Michael Szego

Unity Health Toronto / University of Toronto

David Villeneuve

Canadore College

Bo Wang

Peter Munk Cardiac Centre, UHN / University of Toronto

W-SWootton.jpg

Sarah Wootton

University of Guelph

 

We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.

 

    Partners    

Why rushing COVID-19 booster shots for everyone could do more harm than good

Dr. Allison McGeer, a medical microbiologist and infectious disease specialist at Toronto’s Mount Sinai Hospital, says there are two core reasons why developing a booster that specifically targets delta would be advantageous.

September 4, 2021

COVID-19 Wastewater Surveillance Is Making Campus Safer, Plans to Expand, Says U of G Prof

In the news again, Ontario Genomics supported, University of Guelph and University of Ottawa-led project received nation-wide coverage as a one-of-its-kind wastewater surveillance project for early and effective detection of COVID-19 variants.

September 3, 2021

The Role of Wastewater Testing for SARS-CoV-2 Surveillance

August 26, 2021

Ontario COVID-19 Science Advisory Table members including Robert Delatolla and Allison McGeer explain the Role of Wastewater Testing for SARS-CoV-2 Surveillance. We are early supporters of this incredible work.

 

    Contact    

 

Thanks for submitting!